These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 31304451)
21. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling. Lee S; Lee M; Kim JB; Jo A; Cho EJ; Yu SJ; Lee JH; Yoon JH; Kim YJ Biochem Biophys Res Commun; 2016 May; 473(4):1247-1254. PubMed ID: 27091428 [TBL] [Abstract][Full Text] [Related]
22. TLX3 repressed SNAI1-induced epithelial-mesenchymal transition by directly constraining STAT3 phosphorylation and functionally sensitized 5-FU chemotherapy in hepatocellular carcinoma. Wang C; Dou C; Wang Y; Liu Z; Roberts L; Zheng X Int J Biol Sci; 2019; 15(8):1696-1711. PubMed ID: 31360112 [TBL] [Abstract][Full Text] [Related]
23. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771 [TBL] [Abstract][Full Text] [Related]
24. Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression. Xue F; Liu Y; Zhang H; Wen Y; Yan L; Tang Q; Xiao E; Zhang D Onco Targets Ther; 2016; 9():7253-7261. PubMed ID: 27932893 [TBL] [Abstract][Full Text] [Related]
25. PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway. Zhang XP; Jiang YB; Zhong CQ; Ma N; Zhang EB; Zhang F; Li JJ; Deng YZ; Wang K; Xie D; Cheng SQ Cell Physiol Biochem; 2018; 47(4):1643-1654. PubMed ID: 29945155 [TBL] [Abstract][Full Text] [Related]
26. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells. Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855 [TBL] [Abstract][Full Text] [Related]
27. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma. Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673 [TBL] [Abstract][Full Text] [Related]
28. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
29. Oct4 promotes cancer cell proliferation and migration and leads to poor prognosis associated with the survivin/STAT3 pathway in hepatocellular carcinoma. Wang G; Zhou H; Gu Z; Gao Q; Shen G Oncol Rep; 2018 Aug; 40(2):979-987. PubMed ID: 29901157 [TBL] [Abstract][Full Text] [Related]
30. Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling. Long J; Jiang C; Liu B; Dai Q; Hua R; Chen C; Zhang B; Li H Cancer Lett; 2018 Jun; 423():113-126. PubMed ID: 29196128 [TBL] [Abstract][Full Text] [Related]
31. Mitochondrial GRIM19 Loss Induces Liver Fibrosis through NLRP3/IL33 Activation via Reactive Oxygen Species/NF-кB Signaling. Xu X; Feng J; Wang X; Zeng X; Luo Y; He X; Yang M; Lv T; Feng Z; Bao L; Zhao L; Huang D; Huang Y J Clin Transl Hepatol; 2024 Jun; 12(6):539-550. PubMed ID: 38974954 [TBL] [Abstract][Full Text] [Related]
32. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway. Huang WC; Tung SL; Chen YL; Chen PM; Chu PY BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298 [TBL] [Abstract][Full Text] [Related]
33. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer. Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554 [TBL] [Abstract][Full Text] [Related]
34. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling. Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869 [TBL] [Abstract][Full Text] [Related]
35. Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. Zhang JF; He ML; Fu WM; Wang H; Chen LZ; Zhu X; Chen Y; Xie D; Lai P; Chen G; Lu G; Lin MC; Kung HF Hepatology; 2011 Dec; 54(6):2137-48. PubMed ID: 21809363 [TBL] [Abstract][Full Text] [Related]
36. Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma. Wang H; Su X; Yang M; Chen T; Hou J; Li N; Cao X Oncoimmunology; 2015 Oct; 4(10):e1031440. PubMed ID: 26451302 [TBL] [Abstract][Full Text] [Related]
37. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits. Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422 [TBL] [Abstract][Full Text] [Related]
38. p66Shc promotes HCC progression in the tumor microenvironment via STAT3 signaling. Huang P; Feng X; Zhao Z; Yang B; Fang T; Guo M; Xia J Exp Cell Res; 2019 Oct; 383(2):111550. PubMed ID: 31398350 [TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer. Ma H; Tian T; Liang S; Liu X; Shen H; Xia M; Liu X; Zhang W; Wang L; Chen S; Yu L Oncotarget; 2016 Mar; 7(9):10594-605. PubMed ID: 26871282 [TBL] [Abstract][Full Text] [Related]
40. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma. Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]